Anti-Inflammatory Drug Reduces Nerve Death in Mouse Model of Parkinson's Disease

Nov 07, 2006

Using a mouse model which mimics neuronal cell death in the part of the brain associated with Parkinson’s disease (PD), scientists at the Buck Institute have shown for the first time that these neurons die due to inflammation. The study also shows that treatment with the antibiotic/anti-inflammatory drug minocycline, started before symptoms began to appear, reduced neuronal death in these mice.

The findings, published in November 8 edition of the Journal of Neuroscience, provide a glimpse at potential treatment options for humans and highlight the need for pre-symptomatic tests that would identify those at risk for the disease that affects one out of every 100 people over the age of 65.

The research, led by Buck Institute faculty member Julie Andersen, PhD, involved a mutant mouse known as weaver, so named because it exhibits a loss of balance and motor control early in life. In addition to suffering from a genetically programmed loss of neurons in the cerebellum (the portion of the brain attached to the brain stem) that plays an essential role in coordinating movement), the mice also suffer from nerve death in the substantia nigra, a region in the mid-brain which produces the chemical dopamine that regulates motor control. In humans, PD develops when dopamine levels become deficient, resulting in symptoms which include tremor, slowness of movement, rigidity and problems with balance.

After examining the midbrain of the animals for alterations in gene expression, researchers discovered that weaver mice “over-express” particular genes associated with inflammation compared to normal control littermates. Andersen’s team began treating the mice beginning at birth with minocycline, an antibiotic that also has anti-inflammatory properties. At three weeks of age, the treated mice showed a 30% loss of dopamine-producing neurons in the substantia nigra, as compared to a 50% loss commonly seen in mice not treated with the drug.

“It is satisfying to be able to show that inflammation contributes to dopaminergic cell death in the weaver mouse since neuroinflammation is a commonly observed feature in Parkinson’s disease itself. This suggests that the weaver mouse constitutes a good model to explore potential anti-inflammatory treatments for the human disorder,” said Andersen. She added that the findings also highlight the urgent need to develop tests that would identify at an early age, those at risk for PD. “Currently, by the time humans are diagnosed with Parkinson’s disease they have already lost 60% of their dopamine-producing neurons,” said Andersen, “Anti-inflammatory agents would likely be maximally effective if taken before symptoms appear in order to halt disease progression.”

Others joining Andersen in the study include Buck Institute researchers, Jun Peng, Lin Xie, Fang Fen Stevenson and Simon Melov, along with Dino DiMonte of the Parkinson’s Institute. The work was supported by grants from the National Institutes of Health.

Source: Buck Institute for Age Research

Explore further: Growing a blood vessel in a week

add to favorites email to friend print save as pdf

Related Stories

Animal-free reprogramming of adult cells improves safety

Aug 13, 2014

Human stem cells produced through genetic reprogramming are beset by safety concerns because current techniques alter the DNA of the stem cells and use material from animals to grow them. Now, A*STAR researchers ...

New pathway identified in Parkinson's through brain imaging

Sep 13, 2010

A new study led by researchers at Columbia University Medical Center has identified a novel molecular pathway underlying Parkinson's disease and points to existing drugs which may be able to slow progression of the disease.

Embryonic stem cells: Reprogramming in early embryos

Mar 26, 2014

An Oregon Health & Science University scientist has been able to make embryonic stem cells from adult mouse body cells using the cytoplasm of two-cell embryos that were in the "interphase" stage of the cell ...

A paradigm-shifting step in stem cell research

Dec 31, 2013

(Phys.org) —A team of engineers at the University of Wisconsin-Madison has created a process that may revolutionize stem cell research. The process, outlined in a paper published in Stem Cells on December 19, 2013, will i ...

Recommended for you

Growing a blood vessel in a week

Oct 24, 2014

The technology for creating new tissues from stem cells has taken a giant leap forward. Three tablespoons of blood are all that is needed to grow a brand new blood vessel in just seven days. This is shown ...

Testing time for stem cells

Oct 24, 2014

DefiniGEN is one of the first commercial opportunities to arise from Cambridge's expertise in stem cell research. Here, we look at some of the fundamental research that enables it to supply liver and pancreatic ...

Team finds key signaling pathway in cause of preeclampsia

Oct 23, 2014

A team of researchers led by a Wayne State University School of Medicine associate professor of obstetrics and gynecology has published findings that provide novel insight into the cause of preeclampsia, the leading cause ...

Rapid test to diagnose severe sepsis

Oct 23, 2014

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

User comments : 0